Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1992 1
2001 1
2004 1
2005 1
2011 2
2012 2
2015 7
2016 2
2017 1
2018 1
2019 1
2020 2
2021 6
2022 7
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer.
Whelan TJ, Smith S, Parpia S, Fyles AW, Bane A, Liu FF, Rakovitch E, Chang L, Stevens C, Bowen J, Provencher S, Théberge V, Mulligan AM, Kos Z, Akra MA, Voduc KD, Hijal T, Dayes IS, Pond G, Wright JR, Nielsen TO, Levine MN; LUMINA Study Investigators. Whelan TJ, et al. N Engl J Med. 2023 Aug 17;389(7):612-619. doi: 10.1056/NEJMoa2302344. N Engl J Med. 2023. PMID: 37585627
Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.
Werth VP, Furie RA, Romero-Diaz J, Navarra S, Kalunian K, van Vollenhoven RF, Nyberg F, Kaffenberger BH, Sheikh SZ, Radunovic G, Huang X, Clark G, Carroll H, Naik H, Gaudreault F, Meyers A, Barbey C, Musselli C, Franchimont N; LILAC Trial Investigators. Werth VP, et al. N Engl J Med. 2022 Jul 28;387(4):321-331. doi: 10.1056/NEJMoa2118024. N Engl J Med. 2022. PMID: 35939578 Clinical Trial.
Reporting reproducible imaging protocols.
Larsen DD, Gaudreault N, Gibbs HC. Larsen DD, et al. STAR Protoc. 2023 Mar 17;4(1):102040. doi: 10.1016/j.xpro.2022.102040. Epub 2023 Mar 2. STAR Protoc. 2023. PMID: 36861824 Free PMC article. Review.
Patients recevant un médicament du Programme d'accès spécial au sein d'un centre hospitalier universitaire mère-enfant : démarche de surveillance systématique des demandes, de l'utilisation et de l'innocuité des médicaments sur deux années consécutives.
Corny J, Guérin A, Pelletier E, Atkinson S, Lebel D, Gaudreault P, Bussières JF. Corny J, et al. Can J Hosp Pharm. 2015 Jul-Aug;68(4):332-8. Can J Hosp Pharm. 2015. PMID: 26327708 Free PMC article. French. No abstract available.
TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation.
Ho JSY, Mok BW, Campisi L, Jordan T, Yildiz S, Parameswaran S, Wayman JA, Gaudreault NN, Meekins DA, Indran SV, Morozov I, Trujillo JD, Fstkchyan YS, Rathnasinghe R, Zhu Z, Zheng S, Zhao N, White K, Ray-Jones H, Malysheva V, Thiecke MJ, Lau SY, Liu H, Zhang AJ, Lee AC, Liu WC, Jangra S, Escalera A, Aydillo T, Melo BS, Guccione E, Sebra R, Shum E, Bakker J, Kaufman DA, Moreira AL, Carossino M, Balasuriya UBR, Byun M, Albrecht RA, Schotsaert M, Garcia-Sastre A, Chanda SK, Miraldi ER, Jeyasekharan AD, TenOever BR, Spivakov M, Weirauch MT, Heinz S, Chen H, Benner C, Richt JA, Marazzi I. Ho JSY, et al. Cell. 2021 May 13;184(10):2618-2632.e17. doi: 10.1016/j.cell.2021.03.051. Epub 2021 Mar 30. Cell. 2021. PMID: 33836156 Free PMC article.
Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer.
Johnson DH, Fehrenbacher L, Novotny WF, Herbst RS, Nemunaitis JJ, Jablons DM, Langer CJ, DeVore RF 3rd, Gaudreault J, Damico LA, Holmgren E, Kabbinavar F. Johnson DH, et al. J Clin Oncol. 2023 May 1;41(13):2305-2312. doi: 10.1200/JCO.22.02543. J Clin Oncol. 2023. PMID: 37126944
PATIENTS AND METHODS: In a phase II trial, 99 patients were randomly assigned to bevacizumab 7.5 (n = 32) or 15 mg/kg (n = 35) plus carboplatin (area under the curve = 6) and paclitaxel (200 mg/m(2)) every 3 weeks or carboplatin and paclitaxel alone (n = 32). ...
PATIENTS AND METHODS: In a phase II trial, 99 patients were randomly assigned to bevacizumab 7.5 (n = 32) or 15 mg/kg (n = 35) plus carbopla …
Experimental co-infection of calves with SARS-CoV-2 Delta and Omicron variants of concern.
Cool K, Gaudreault NN, Trujillo JD, Morozov I, McDowell CD, Bold D, Kwon T, Balaraman V, Assato P, Madden DW, Mantlo E, Souza-Neto J, Matias-Ferreyra F, Retallick J, Singh G, Schotsaert M, Carossino M, Balasuriya UBR, Wilson WC, Pogranichniy RM, García-Sastre A, Richt JA. Cool K, et al. Emerg Microbes Infect. 2024 Dec;13(1):2281356. doi: 10.1080/22221751.2023.2281356. Epub 2023 Dec 30. Emerg Microbes Infect. 2024. PMID: 37938158 Free PMC article.
RT-qPCR genotyping assays for differentiating Rift Valley fever phlebovirus strains.
Balaraman V, Gaudreault NN, Trujillo JD, Indran SV, Wilson WC, Richt JA. Balaraman V, et al. J Virol Methods. 2023 May;315:114693. doi: 10.1016/j.jviromet.2023.114693. Epub 2023 Feb 16. J Virol Methods. 2023. PMID: 36801236 Free PMC article.
Our data shows that the GT assays are capable of differentiating L, M, and S segments of RVFV strains 128B-15 versus MP-12, and 128B-15 versus SA01-1322. ...
Our data shows that the GT assays are capable of differentiating L, M, and S segments of RVFV strains 128B-15 versus MP-12, and 128B- …
Granularity of SERPINA1 alleles by DNA sequencing in CanCOLD.
Gupta N, Gaudreault N, Thériault S, Li PZ, Henry C, Kirby M, Maltais F, Tan W, Bourbeau J, Bossé Y; Canadian Respiratory Research Network and the CanCOLD study group. Gupta N, et al. Eur Respir J. 2020 Oct 15;56(4):2000958. doi: 10.1183/13993003.00958-2020. Print 2020 Oct. Eur Respir J. 2020. PMID: 32482783 Free article.
43 results